These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31869557)

  • 41. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections.
    Zlamy M; Kofler S; Orth D; Würzner R; Heinz-Erian P; Streng A; Prelog M
    BMC Infect Dis; 2013 Mar; 13():112. PubMed ID: 23452879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in diarrhea hospitalizations among infants at three hospitals in Tanzania before and after rotavirus vaccine introduction.
    Lyamuya F; Michael F; Jani B; Fungo Y; Chambo A; Chami I; Bulali R; Mpamba A; Cholobi H; Kallovya D; Kamugisha C; Mwenda JM; Cortese MM
    Vaccine; 2018 Nov; 36(47):7157-7164. PubMed ID: 29655628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
    Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
    Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.
    Kõivumägi K; Toompere K; Soeorg H; Kallas E; Jõgeda EL; Huik K; ; Lutsar I
    Vaccine; 2020 Mar; 38(13):2879-2886. PubMed ID: 32067818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.
    Richardson V; Hernandez-Pichardo J; Quintanar-Solares M; Esparza-Aguilar M; Johnson B; Gomez-Altamirano CM; Parashar U; Patel M
    N Engl J Med; 2010 Jan; 362(4):299-305. PubMed ID: 20107215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program.
    Gurgel RG; Bohland AK; Vieira SC; Oliveira DM; Fontes PB; Barros VF; Ramos MF; Dove W; Nakagomi T; Nakagomi O; Correia JB; Cunliffe N; Cuevas LE
    Gastroenterology; 2009 Dec; 137(6):1970-5. PubMed ID: 19632228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance and challenges of accurately counting rotavirus deaths in China, 2002.
    Yee EL; Fang ZY; Liu N; Hadler SC; Liang X; Wang H; Zhu X; Jiang B; Parashar U; Widdowson MA; Glass RI
    Vaccine; 2009 Nov; 27 Suppl 5():F46-9. PubMed ID: 19931719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state.
    Chang HG; Smith PF; Ackelsberg J; Morse DL; Glass RI
    Pediatrics; 2001 Jul; 108(1):54-60. PubMed ID: 11433054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel.
    Muhsen K; Rubenstein U; Kassem E; Goren S; Schachter Y; Kremer A; Shulman LM; Ephros M; Cohen D
    Hum Vaccin Immunother; 2015; 11(10):2475-82. PubMed ID: 26212174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.
    Rahajamanana VL; Raboba JL; Rakotozanany A; Razafindraibe NJ; Andriatahirintsoa EJPR; Razafindrakoto AC; Mioramalala SA; Razaiarimanga C; Weldegebriel GG; Burnett E; Mwenda JM; Seheri M; Mphahlele MJ; Robinson AL
    Vaccine; 2018 Nov; 36(47):7198-7204. PubMed ID: 28958809
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.
    Armah G; Pringle K; Enweronu-Laryea CC; Ansong D; Mwenda JM; Diamenu SK; Narh C; Lartey B; Binka F; Grytdal S; Patel M; Parashar U; Lopman B
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S200-7. PubMed ID: 27059357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-licensure experience with rotavirus vaccination in Latin America and the Caribbean: a systematic review and meta-analysis.
    Chavers T; De Oliveira LH; Parashar UD; Tate JE
    Expert Rev Vaccines; 2018 Nov; 17(11):1037-1051. PubMed ID: 30365904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom.
    Marlow R; Muir P; Vipond B; Lyttle M; Trotter C; Finn A
    Euro Surveill; 2015; 20(48):30077. PubMed ID: 26675375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time series investigation of changes in seasonality of acute diarrhea hospitalizations before and after rotavirus vaccine in Southern Brazil.
    Masukawa ML; Souza EM; Gimenes E; Uchimura NS; Moriwaki AM; Uchimura TT
    Cad Saude Publica; 2016 Oct; 32(10):e00080515. PubMed ID: 27783754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia.
    Sanneh B; Papa Sey A; Shah M; Tate J; Sonko M; Jagne S; Jarju M; Sowe D; Taal M; Cohen A; Parashar U; Mwenda JM
    Vaccine; 2018 Nov; 36(47):7179-7184. PubMed ID: 29544688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of non-routine rotavirus vaccination on hospitalizations for diarrhoea and rotavirus infections in Spain.
    Gil-Prieto R; Gonzalez-Escalada A; Alvaro-Meca A; Garcia-Garcia L; San-Martin M; González-López A; Gil-de-Miguel A
    Vaccine; 2013 Oct; 31(43):5000-4. PubMed ID: 23911782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland.
    Maphalala G; Phungwayo N; Masona G; Lukhele N; Tsegaye G; Dube N; Sindisiwe D; Khumalo L; Daniel F; Katsande R; Tate JE; Mwenda JM; Weldegebriel G
    Vaccine; 2018 Nov; 36(47):7210-7214. PubMed ID: 28778615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.
    Tate JE; Burton AH; Boschi-Pinto C; Parashar UD;
    Clin Infect Dis; 2016 May; 62 Suppl 2():S96-S105. PubMed ID: 27059362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.